Shopping Cart
Remove All
Your shopping cart is currently empty
(±)13(14)-DiHDPA is a metabolite of docosahexaenoic acid that is produced via oxidation by cytochrome P450 epoxygenases. Epoxygenase metabolites of DHA, including (±)13(14)-DiHDPA, are reported to inhibit angiogenesis, tumor growth, and metastasis.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 50 μg | $297 | 35 days | 35 days | |
| 100 μg | $526 | 35 days | 35 days | |
| 500 μg | $2,130 | 35 days | 35 days | |
| 1 mg | $3,370 | 35 days | 35 days |
| Description | (±)13(14)-DiHDPA is a metabolite of docosahexaenoic acid that is produced via oxidation by cytochrome P450 epoxygenases. Epoxygenase metabolites of DHA, including (±)13(14)-DiHDPA, are reported to inhibit angiogenesis, tumor growth, and metastasis. |
| Molecular Weight | 362.51 |
| Formula | C22H34O4 |
| Cas No. | 1345275-24-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | Ethanol: 50 mg/mL (137.93 mM), Sonication is recommended. DMF: 50 mg/mL (137.93 mM), Sonication is recommended. PBS (pH 7.2): 0.25 mg/mL (0.69 mM), Sonication is recommended. DMSO: 50 mg/mL (137.93 mM), Sonication is recommended. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.